{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:06:38Z","timestamp":1790690798212,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100016127","name":"European Refugee Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016127","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/17471-7"],"award-info":[{"award-number":["2017\/17471-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021683","name":"Fondations communautaires du Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021683","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["465434\/2014-2"],"award-info":[{"award-number":["465434\/2014-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.vaccine.2020.03.037","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T02:51:55Z","timestamp":1585795915000},"page":"3653-3664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses"],"prefix":"10.1016","volume":"38","author":[{"given":"Marcelo Pires","family":"Amaral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana de Souza","family":"Apostolico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e1dia","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Caroline","family":"Coirada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vict\u00f3ria Alves Santos","family":"Lunardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar Ruz","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Higo Fernando Santos","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato Mancini","family":"Astray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Beatriz","family":"Boscardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Santoro","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.03.037_b0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus. I. Isolations and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"10.1016\/j.vaccine.2020.03.037_b0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0035-9203(64)90201-9","article-title":"Zika virus infection in man","volume":"58","author":"Simpson","year":"1964","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"10.1016\/j.vaccine.2020.03.037_b0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1473-3099(16)30525-4","article-title":"First published report of Zika virus infection in people: Simpson, not MacNamara","volume":"17","author":"Wikan","year":"2017","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.vaccine.2020.03.037_b0020","unstructured":"WHO. Zika Virus, Microcephaly, Guillain-Barr\u00e9 Syndrome. In: Report S, editor. World Health Organization; 2017."},{"key":"10.1016\/j.vaccine.2020.03.037_b0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1473-3099(17)30727-2","article-title":"Association between microcephaly, Zika virus infection, and other risk factors in Brazil: final report of a case-control study","volume":"18","author":"de Araujo","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.037_b0030","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMc1605898","article-title":"Miscarriage Associated with Zika Virus Infection","volume":"375","author":"van der Eijk","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.03.037_b0035","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.03.037_b0040","article-title":"Increased rates of Guillain-Barre syndrome associated with Zika virus outbreak in the Salvador metropolitan area","volume":"11","author":"Styczynski","year":"2017","journal-title":"Brazil. PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2020.03.037_b0045","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(17)31450-2","article-title":"An update on Zika virus infection","volume":"390","author":"Baud","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.03.037_b0050","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.aaf5316","article-title":"The 3.8 A resolution cryo-EM structure of Zika virus","volume":"352","author":"Sirohi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.03.037_b0055","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody","volume":"19","author":"Dai","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2020.03.037_b0060","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.03.037_b0065","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"issue":"597\u2013609","key":"10.1016\/j.vaccine.2020.03.037_b0070","article-title":"Recurrent potent human neutralizing antibodies to zika virus in Brazil and Mexico","volume":"169","author":"Robbiani","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2020.03.037_b0075","doi-asserted-by":"crossref","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil","author":"Larocca","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.03.037_b0080","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2016.07.020","article-title":"Structural basis of Zika virus-specific antibody protection","volume":"166","author":"Zhao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2020.03.037_b0085","doi-asserted-by":"crossref","first-page":"369ra179","DOI":"10.1126\/scitranslmed.aai8336","article-title":"Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus","volume":"8","author":"Wang","year":"2016","journal-title":"Sci Transl Med."},{"key":"10.1016\/j.vaccine.2020.03.037_b0090","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.celrep.2018.04.005","article-title":"A single injection of human neutralizing antibody protects against Zika virus infection and microcephaly in developing mouse embryos","volume":"23","author":"Li","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2020.03.037_b0095","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124588","article-title":"Human antibody response to Zika targets type-specific quaternary structure epitopes","volume":"4","author":"Collins","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.vaccine.2020.03.037_b0100","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/S1473-3099(18)30063-X","article-title":"Development of vaccines against Zika virus","volume":"18","author":"Poland","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.037_b0105","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys","author":"Abbink","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.03.037_b0110","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nm.4322","article-title":"A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models","volume":"23","author":"Shan","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2020.03.037_b0115","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41467-017-00737-8","article-title":"A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage","volume":"8","author":"Shan","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2020.03.037_b0120","doi-asserted-by":"crossref","first-page":"10047","DOI":"10.1038\/s41598-017-10595-5","article-title":"Immunization with truncated envelope protein of Zika virus induces protective immune response in mice","volume":"7","author":"Han","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.03.037_b0125","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/s41598-017-08247-9","article-title":"Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.03.037_b0130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.aai9137","article-title":"Rapid development of a DNA vaccine for Zika virus","volume":"354","author":"Dowd","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.03.037_b0135","article-title":"Safety and immunogenicity of an anti-Zika virus DNA vaccine - preliminary report","author":"Tebas","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.03.037_b0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.03.037_b0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41426-018-0161-7","article-title":"Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone","volume":"7","author":"Touret","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2020.03.037_b0150","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41467-018-02975-w","article-title":"Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone","volume":"9","author":"Li","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2020.03.037_b0155","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00055-16","article-title":"The antigenic structure of Zika virus and its relation to other flaviviruses: implications for infection and immunoprophylaxis","volume":"81","author":"Heinz","year":"2017","journal-title":"Microbiol Mol Biol Rev."},{"key":"10.1016\/j.vaccine.2020.03.037_b0160","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials","volume":"391","author":"Gaudinski","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.03.037_b0165","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1080\/14712598.2018.1526277","article-title":"Rapid travel to a Zika vaccine: are we heading towards success or more questions?","volume":"18","author":"Britto","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2020.03.037_b0170","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fimmu.2017.00101","article-title":"Dendritic cell targeting effectively boosts T cell responses elicited by an HIV multiepitope DNA vaccine","volume":"8","author":"Apostolico","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.03.037_b0175","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.vaccine.2020.03.037_b0180","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.20121517","article-title":"Revealing the role of CD4(+) T cells in viral immunity","volume":"209","author":"Sant","year":"2012","journal-title":"J Exp Med."},{"key":"10.1016\/j.vaccine.2020.03.037_b0185","article-title":"DNA vaccines: How much have we accomplished in the last 25 years?","volume":"6","author":"Rosa","year":"2015","journal-title":"J Vacc Vacc"},{"key":"10.1016\/j.vaccine.2020.03.037_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194860","article-title":"Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice","volume":"13","author":"Liang","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.03.037_b0195","first-page":"1459394","article-title":"Adjuvants: classification, modus operandi, and licensing","volume":"2016","author":"Apostolico Jde","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2020.03.037_b0200","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1182\/blood-2011-10-388579","article-title":"Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates","volume":"119","author":"Kwissa","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2020.03.037_b0205","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/14760584.2015.966085","article-title":"Vaccine adjuvant uses of poly-IC and derivatives","volume":"14","author":"Martins","year":"2015","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2020.03.037_b0210","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.4049\/jimmunol.170.6.3059","article-title":"The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets","volume":"170","author":"Hemmi","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.03.037_b0215","doi-asserted-by":"crossref","unstructured":"Shirota H, Klinman DM. CpG oligodeoxynucleotides as adjuvants for clinical use. In: Virgil EJC, Schijns DTOH, editors. Immunopotentiators in modern vaccines, second ed.; 2017.","DOI":"10.1016\/B978-0-12-804019-5.00009-8"},{"key":"10.1016\/j.vaccine.2020.03.037_b0220","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2014.09.010","article-title":"Poly(I:C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs","volume":"146","author":"Ammi","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.vaccine.2020.03.037_b0225","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1016\/j.vaccine.2017.04.052","article-title":"Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus","volume":"35","author":"Yang","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.037_b0230","doi-asserted-by":"crossref","first-page":"15743","DOI":"10.1038\/ncomms15743","article-title":"DNA vaccination protects mice against Zika virus-induced damage to the testes","volume":"8","author":"Griffin","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2020.03.037_b0235","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao4163","article-title":"Durability and correlates of vaccine protection against Zika virus in rhesus monkeys","volume":"9","author":"Abbink","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2020.03.037_b0240","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ebiom.2017.10.006","article-title":"A DNA vaccine protects human immune cells against zika virus infection in humanized mice","volume":"25","author":"Yi","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2020.03.037_b0245","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0042-6822(02)00028-4","article-title":"Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus","volume":"306","author":"Chang","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.03.037_b0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007226","article-title":"Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment","volume":"4","author":"Roos","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.03.037_b0255","doi-asserted-by":"crossref","first-page":"12204","DOI":"10.1038\/ncomms12204","article-title":"A rhesus macaque model of Asian-lineage Zika virus infection","volume":"7","author":"Dudley","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2020.03.037_b0260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.chom.2016.12.010","article-title":"Mapping and role of the CD8+ T cell response during primary Zika virus infection in mice","volume":"21","author":"Elong Ngono","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2020.03.037_b0265","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-017-01669-z","article-title":"Dengue virus-reactive CD8(+) T cells mediate cross-protection against subsequent Zika virus challenge","volume":"8","author":"Wen","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2020.03.037_b0270","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1038\/s41467-018-05458-0","article-title":"Cross-reactive Dengue virus-specific CD8(+) T cells protect against Zika virus during pregnancy","volume":"9","author":"Regla-Nava","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2020.03.037_b0275","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1038\/s41467-018-05519-4","article-title":"Critical role of CD4(+) T cells and IFNgamma signaling in antibody-mediated resistance to Zika virus infection","volume":"9","author":"Lucas","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2020.03.037_b0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007237","article-title":"CD4+T cells mediate protection against Zika associated severe disease in a mouse model of infection","volume":"14","author":"Hassert","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2020.03.037_b0285","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00038-18","article-title":"Cellular and humoral immunity protect against vaginal Zika virus infection in mice","author":"Scott","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.03.037_b0290","article-title":"CD4+ T cells promote humoral immunity and viral control during Zika virus infection","volume":"15","author":"Elong Ngono","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2020.03.037_b0295","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1084\/jem.20151517","article-title":"Human T cell responses to Japanese encephalitis virus in health and disease","volume":"213","author":"Turtle","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2020.03.037_b0300","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2020.03.037_b0305","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:42:27Z","timestamp":1759401747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20304163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":61,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0264410X20304163"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}